AI Article Synopsis
- The study assessed the effects of levetiracetam (LEV) combined with sodium valproate (SV) on pediatric epilepsy and its influence on serum miR-106b levels in children.
- One hundred and twenty children were divided into a control group receiving only SV and an observation group receiving both SV and LEV, with results showing that the observation group had significantly better clinical outcomes.
- The expression of serum miR-106b was lower in the observation group and it may serve as a useful diagnostic and prognostic marker for pediatric epilepsy, with a cut-off value identified for its effectiveness.
Article Abstract
Efficacy of levetiracetam (LEV) combined with sodium valproate (SV) on pediatric epilepsy and its effect on serum miR-106b in children were investigated. One hundred and twenty children with epilepsy in Xuzhou Children's Hospital from July 2015 to July 2017 were enrolled, and divided into control group (n=60) and observation group (n=60) according to random sampling. Additionally, 100 children undergoing normal physical examination were collected as normal group. Patients in the control group were treated with SV, and patients in the observation group were treated with SV and LEV. RT-qPCR was used for detecting the relative expression of serum miR-106b in children. The clinical efficacy was evaluated. After treatment, the relative expression of serum miR-106b in the control group was significantly higher than that in the observation group (P<0.05). The difference in the control group was smaller than that in the observation group (P<0.05). According to the ROC curve analysis, when the cut-off value was 1.442, the sensitivity, specificity and area under curve (AUC) of miR-106b in the diagnosis of pediatric epilepsy were 94.00, 64.17 and 0.833 respectively. The clinical efficacy in the observation group was significantly better than that in the control group (P<0.05). Spearman's test showed that the expression of miR-106b gradually decreased with the continuous improvement of the clinical efficacy (P<0.05). The AUC of miR-106b was 0.833, 95% CI: 0.779 to 0.887, the cut-off was 1.442. LEV combined with SV is effective in the treatment of children with epilepsy, and does not increase the clinical ADR. The expression of serum miR-106b in children can be used as a clinical prognostic indicator and a potential diagnostic indicator.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862620 | PMC |
| http://dx.doi.org/10.3892/etm.2019.8098 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mechanism of TGIF1 on glycolipid metabolism disorders in mice with type 2 diabetes.
BMJ Open Diabetes Res Care
January 2025
The Second Affiliated Hospital of Shandong First Medical University, Tai'an, Shandong, China
Introduction: Type 2 diabetes (T2D) is a chronic condition characterized by high levels of blood glucose resulting from the inefficiency of insulin. This study aims to explore the mechanism of TGFB-induced factor homeobox 1 (TGIF1) in the glycolipid metabolism of mice with T2D.
Research Design And Methods: Mice with T2D were induced by high-fat diet and low-dose streptozotocin (STZ) injection.
Impact of protein kinase CK2 downregulation and inhibition on oncomir clusters 17 ~ 92 and 106b ~ 25 in prostate, breast, and head and neck cancers.
Mol Med
October 2024
Research Service, Minneapolis VA Health Care System, Minneapolis, MN, 55417, USA.
Article Synopsis
- * A study used PCR analysis to observe how downregulating CK2 affects the levels of specific oncomir clusters (miR-17 ~ 92 and miR-106b ~ 25) in different cancer cell types, including prostate and breast cancers.
- * Results indicated that reducing CK2 expression or activity significantly lowered the levels of these oncomirs, suggesting a potential link between CK2 and the regulation of these specific microRNAs in cancer cells.
Potential diagnostic value of circulating miRNAs in HFrEF and bioinformatics analysis.
Heliyon
October 2024
Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Background: Few studies have compared the performances of those reported miRNAs as biomarkers for heart failure with reduced EF (HFrEF) in a population at high risk. The purpose of this study is to investigate comprehensively the performance of those miRNAs as biomarkers for HFrEF.
Methods: By using bioinformatics methods, we also examined these miRNAs' target genes and possible signal transduction pathways.
Identification and evaluation of a serum microRNA panel to diagnose colorectal cancer patients.
Int J Cancer
February 2025
Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
Screening plays a crucial role in the early detection of colorectal cancer, greatly reducing mortality rates. The objective of this study was to identify a non-invasive diagnostic method utilizing serum microRNA expression for the diagnosis of colorectal cancer patients. The study consisted of three stages.
View Article and Find Full Text PDFmiR-21, miR-29a, and miR-106b: serum and tissue biomarkers with diagnostic potential in metastatic testicular cancer.
Sci Rep
August 2024
Department of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
The imperative need for sensitive and precise tools is underscored in cancer diagnostics, with biomarkers playing a pivotal role in facilitating early detection and tumor diagnosis. Despite their classical pathological classification, testicular tumors lack valuable markers, emphasizing the necessity to identify and apply serum tumor markers in clinical management. Unfortunately, existing biomarkers exhibit limited sensitivities and specificities.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!